Found: 3
Select item for more details and to access through your institution.
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1135815
- By:
- Publication type:
- Article
Characterization of Unique Pathological Features of COVID-Associated Coagulopathy: Studies with AC70 hACE2 Transgenic Mice Highly Permissive to SARS-CoV-2 Infection.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 6, p. 1, doi. 10.1371/journal.ppat.1011777
- By:
- Publication type:
- Article
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 738, p. 1, doi. 10.1126/scitranslmed.adi0979
- By:
- Publication type:
- Article